Next year, Kaleo plans to release Auvi-Q 0.1 mg, a version of its epinephrine auto-injector for infants and small children. Kaleo said Monday that the Food and Drug Administration has approved its supplemental New Drug Application (sNDA) for Auvi-Q 0.
The Nestlé board of directors has decided to change the organization of the infant nutrition business at Nestlé to enhance further the company’s ability to win in this high-growth category.
Merck has received approval for a new version of GONAL-f (follitropin alfa injection) prefilled pen from the U.S. Food and Drug Administration (FDA). Known as GONAL-f RFF Redi-ject prefilled pen in the U.S.
AstraZeneca plans to release Fasenra, its newly approved biologic drug for severe asthma, to U.S. pharmacies in the coming weeks.
Culturelle is launching Culturelle Baby, a new line of probiotics formulated for children up to 24 months. The i-Health Inc.
SinfulColors has delved into the color cosmetics market with the introduction of a new makeup collection and the signing of actress and singer Vanessa Hudgens as global color collaborator.
Building on its efforts to fight the opioid abuse epidemic, Cardinal Health Inc. has launched an initiative targeting one of the nation’s hardest-hit areas.
Health screening kiosk maker higi SH LLC welcomed reduced standards for high blood pressure (BP) released this week by the American Heart Association (AHA) and the American College of Cardiology (ACC).
Cardinal Health Inc. plans to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion.
Sales and marketing firm Advantage Solutions is buying retail and brand marketing specialist Daymon Worldwide. Financial terms of the transaction weren’t disclosed. Under the agreement, Daymon will continue to operate as a separate legal entity at its Stamford, Conn., headquarters.
Upsher-Smith Laboratories LLC said its Japan-based parent, Sawai Pharmaceutical Co., has agreed to sell a 20% stake in its Sawai America Inc. subsidiary to Sumitomo Corp. of Americas (SCOA). Under the deal, SCOA — part of global conglomerate Sumitomo Corp.
Crossmark Canada has promoted Kim Thompson to senior vice president of client and business development and hired Steve Noble as director for Marketing Werks.
Innovus Pharmaceuticals Inc. has begun rolling out FlutiCare OTC allergy nasal spray to U.S. pharmacies.
In a fine-tuning of its executive leadership, Pfizer Inc. has named Albert Bourla as chief operating officer, a newly created position. Pfizer said Bourla, 56, currently group president of the Pfizer Innovative Health business unit, is slated to start in the COO role on Jan. 1.
FORT WORTH – Eosera Inc. has made its earwax dissolving product, Earwax MD, available in the Canadian market on Amazon.ca. Eosera said Tuesday that the Canadian market rollout marks the beginning of the company’s international expansion. On Amazon.
Next week, Lil’ Drug Store Products Inc. plans to begin distribution of its NoDoz alertness aid caplets to the convenience store channel. Lil’ Drug Store Products said Monday that NoDoz alertness aid caplets will be available for shipment to convenience stores starting on Nov. 20.
